NeuClone’s Trastuzumab Trial Succeeds
Reports Successful Phase I Trial For NeuCeptin Trastuzumab Biosimilar
• By Akriti Seth
NeuClone and partner Serum Institute of India have reported success in a phase I trial for trastuzumab • Source: Shutterstock 
